Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2013-2017

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 12.1 (12.1, 12.2) 44,614 63.1
Wisconsin 6 *** 14.9 (14.4, 15.3) 1,032 72.0
Maine 6 *** 14.7 (13.9, 15.5) 271 71.5
Iowa 3 *** 14.6 (14.1, 15.2) 547 69.1
Minnesota 6 *** 14.5 (14.1, 14.9) 915 68.0
Delaware 6 *** 14.3 (13.3, 15.3) 168 70.7
Pennsylvania 6 *** 14.1 (13.9, 14.4) 2,306 67.3
Vermont 6 *** 14.1 (12.9, 15.4) 115 69.4
Kentucky 3 *** 13.7 (13.3, 14.2) 714 68.4
New Hampshire 6 *** 13.7 (12.9, 14.6) 232 65.6
Nebraska 6 *** 13.7 (13.0, 14.4) 295 66.8
South Dakota 6 *** 13.7 (12.6, 14.8) 136 71.5
West Virginia 6 *** 13.3 (12.6, 14.0) 325 68.9
Missouri 6 *** 13.2 (12.9, 13.6) 967 70.7
New York 3 *** 13.2 (13.0, 13.4) 3,045 61.1
Illinois 6 *** 13.1 (12.8, 13.4) 1,895 67.2
Michigan 5 *** 13.1 # (12.8, 13.4) 1,567 66.5
North Dakota 6 *** 13.0 (11.9, 14.2) 110 69.1
Connecticut 3 *** 13.0 (12.5, 13.5) 576 61.6
Idaho 3 *** 13.0 (12.2, 13.7) 238 67.1
Ohio 6 *** 12.9 (12.6, 13.2) 1,810 67.2
New Jersey 3 *** 12.9 (12.6, 13.2) 1,347 59.3
Maryland 6 *** 12.9 (12.5, 13.3) 870 71.6
Indiana 6 *** 12.8 (12.4, 13.2) 963 68.8
Rhode Island 6 *** 12.8 (11.9, 13.7) 165 63.3
Montana 6 *** 12.7 (11.9, 13.7) 167 67.9
Utah 3 *** 12.7 (12.1, 13.3) 324 68.2
Oregon 6 *** 12.7 (12.2, 13.1) 619 66.6
Kansas 6 *** 12.4 (11.9, 13.0) 411 64.1
Louisiana 3 *** 12.3 (11.9, 12.8) 634 64.4
Washington 5 *** 12.1 (11.8, 12.5) 974 61.9
Massachusetts 3 *** 12.1 (11.8, 12.5) 978 67.2
Georgia 3 *** 12.1 (11.7, 12.4) 1,270 66.5
Colorado 6 *** 12.0 (11.6, 12.5) 684 70.0
California 3 *** 12.0 (11.8, 12.1) 4,943 65.3
North Carolina 6 *** 11.9 (11.7, 12.2) 1,386 68.1
Oklahoma 6 *** 11.6 (11.1, 12.0) 509 64.1
Virginia 6 *** 11.3 (10.9, 11.6) 1,056 66.1
Tennessee 6 *** 11.1 (10.8, 11.5) 863 63.3
Arkansas 6 *** 11.1 (10.6, 11.6) 393 61.0
Mississippi 6 *** 10.9 (10.4, 11.4) 364 64.7
Florida 6 *** 10.8 (10.6, 11.0) 2,905 44.7
South Carolina 6 *** 10.7 (10.3, 11.1) 623 63.3
Alaska 6 *** 10.1 (9.0, 11.3) 69 60.4
Texas 6 *** 10.0 (9.8, 10.1) 2,643 57.7
Wyoming 6 *** 9.8 (8.7, 10.9) 64 57.0
Alabama 6 *** 9.7 (9.3, 10.1) 559 59.7
Hawaii 3 *** 9.5 (8.8, 10.2) 166 57.9
Nevada 6 *** 9.2 (8.7, 9.6) 295 60.2
District of Columbia 6 *** 9.1 (8.1, 10.2) 60 59.8
Arizona 6 *** 9.0 (8.8, 9.4) 732 58.5
New Mexico 3 *** 8.3 (7.8, 8.8) 205 54.9
Puerto Rico 6 *** 6.4 (6.1, 6.8) 281 45.3
Notes:
Created by statecancerprofiles.cancer.gov on 08/07/2020 6:11 pm.

*** No Healthy People 2020 Objective for this cancer.

State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Health Service Areas are a single county or cluster of contiguous counties which are relatively self-contained with respect to hospital care. For more detailed information, please see Health Service Area information page.
# Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
3 Source: SEER November 2019 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission).

Please note that the data comes from different sources. Due to different years of data availablility, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each graph for additional information.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top